PARTNER | HE, HIM, HIS
in | Office: 202 935 6076 | Direct: 202 601 8568
—
Max Voldman is a partner at Whistleblower Partners. Max’s practice is focused on representing whistleblowers under the federal False Claims Act and numerous state law equivalents, and the whistleblower programs of the Internal Revenue Service, Securities and Exchange Commission, Commodity Futures Trading Commission, and Department of Transportation.He is part of the legal team pursuing a qui tam case against UnitedHealth Group alleging the nation’s largest Medicare Advantage Organization submitted false claims for payment to the Medicare Program by improperly inflating its members’ risk scores. Max also has experience analyzing complex data sets, developing damages models, and assisting with statistical analyses. He has also published numerous articles on issues of healthcare law, whistleblower programs, and environmental issues.
Max worked in State Farm’s actuarial science department and coached the debate team for a high school in Illinois, including one team that won the State Championship. He is fluent in Russian.
In his spare time, Max enjoys hiking, tennis, and is, unfortunately, a devoted fan of the Chicago Bears.
United States ex rel. Poehling v. UnitedHealth Group, Inc., No. 2:16-cv-08697 (C.D. Cal.): Represents a whistleblower alleging that Defendants, the nation's largest Medicare Advantage Plan exaggerated the sickliness of their insured population in a scheme to collect billions in additional premiums from the government.
United States and State of New York ex rel. Lacey v. Visiting Nurse Service of New York, No. 1:14-cv-05739 (S.D.N.Y.): Represented a whistleblower alleging that a home healthcare company systematically provided fewer services to Medicare and Medicaid beneficiaries than were order by those beneficiaries’ physicians. The case settled in 2020 for $57 million.
United States ex rel. Taylor v. Kaiser Permanente, No. 3:21-cv-03894 (N.D. Cal.): Represents a whistleblower alleging that Kaiser Permanente defrauded the Medicare Advantage Program in a variety of ways, including exaggerating the sickliness of their covered population, improper coding practices, and improper practices concerning addenda.
“Could AI One Day Be a Whistleblower?,” Newsweek (May 23, 2024)
“Telehealth Boomed During the Pandemic - And So Did Telehealth Fraud,” Constantine Cannon Blog (August 24, 2022)
“The Theranos Saga Underlines the Need to Expand Whistleblower Reward Programs,” Fortune (July 22, 2022) (with Gordon Schnell) (paywall)
“Ohio Needs False Claims Act for Taxpayers,” The Cincinnati Enquirer(March 8, 2022) (with Hallie Noecker)
“Whistleblowers Are Key to Reining in Prescription Drug Costs,” Newsweek (March 17, 2022) (with Gordon Schnell)
“Give Whistleblowers the Ability to Fight Fraud Everywhere,” The Colorado Sun (March 12, 2022) (with Gordon Schnell)
“Government’s Crackdown on Risk Adjustment Fraud Continues,” RACmonitor (September 29, 2021) (with Mary Inman)
“Sutter Health: Latest Part C Participant to Settle on Whistleblower Allegations,” RACmonitor (September 22, 2021)
“A New Day for Data Whistleblowers: In a Historic First, DOJ Joins False Claims Act Case,” RACmonitor (June 16, 2021)
"Kickbacks in the Medicare Advantage Program: $12.5 million Settlement in Whistleblower Case," RACmonitor (February 17, 2021) (with Mary Inman)
“Incoming HHS Secretary Becerra Will Be a Champion For Whistle-Blowers,” San Francisco Chronicle (January 20, 2021) (with Gordon Schnell) (paywall)
“Wanted: A Corporate Crimebuster at the DOJ,” The Crime Report (December 22, 2020) (with Gordon Schnell)
“Why the Federal Government Must Toughen Standards for Future CARES Act Relief,” The Tennessean (October 27, 2020) (with Gordon Schnell)
“Include Insurance Fraud in Whistleblower Reward Program,” The Albany Times Union (October 18, 2020) (with Gordon Schnell)
“A Better Approach to Fighting Fraud in West-Virginia: Bring In the Whistleblowers,” The Dominion Post (October 12, 2020) (with Gordon Schnell)
“Whistleblowers Could Bring In Money for Kansas. Why Did Lawmakers Say No?,” Kansas City Star (August 1, 2020) (with Gordon Schnell)
“Let the Whistles Blow: Never Mind the Trump Administration; Listen to Those Calling Out Wrongdoing,” New York Daily News (May 9, 2020) (with Gordon Schnell)
“Coronavirus Relief Bill: We Must Guard the Floodgates of Fraud,” The Globe Post (April 17, 2020) (with Gordon Schnell)
“It Looked Like Charity But It Was Actually Big Pharma's Way to Keep Drug Prices High,” The Star Ledger (March 17, 2020) (with Gordon Schnell)
“Data Analysts: A New Kind of Whistleblower to ‘Catch a Rogue’?,” STAT News (March 16, 2020) (with Gordon Schnell)
“What’s Missing From the Debate About ‘Medicare for All’? Combating Billions in Healthcare Fraud,” FIERCE Healthcare (October 21, 2019) (with Gordon Schnell)
Nina Youngstrom, “Court OKs Insurer’s FCA Lawsuit Against Lab After Private Lawsuit,” COSMOS (June 10, 2024)
Nina Youngstrom, “Compliance Profession’s Allegations of Software Tampering Survive in Kaiser Case,” COSMOS (February 26, 2024)
Nina Youngstrom, “As ‘Originator’ of Codes for HCCs, Providers Face Their Own Risk From Crackdown on MA Plans,” COSMOS (October 30, 2023)
Eleanor Laise, “Pfizer Loses Court Battle Over Drug Copay Assistance Program With Big Implications For Medicare Spending,” MarketWatch (July 27, 2022)
Eleanor Laise, “Pfizer Loses Legal Battle With Big Implications for Drug Pricing,” MarketWatch (October 1, 2021)
Tara Bannow, “DOJ Intervenes in False Claims Act Suit Against Medicare Advantage Insurer,” Modern Healthcare (September 14, 2021) (paywall)
Fred Schulte, “Justice Department Targets Data Mining in Medicare Advantage Fraud Case,” Kaiser Health News & NPR (September 14, 2021)
Nina Youngstrom, “DOJ Intervenes in FCA Complaints Against Kaiser Plan, Medical Groups,” COSMOS (August 23, 2021)
Melanie Conklin, “Is ALEC Helping Republicans Campaign in Violation of Its Tax Status,” Wisconsin Examiner (July 27, 2021)
Nina Youngstrom, “DOJ Intervenes in FCA Suit Filed by ‘Data Whistleblower,’ Adding Insider Allegations,” COSMOS (June 21, 2021)
Christopher Brown, “Pfizer Lawsuit Tests Crackdown on Drugmakers Picking Up Copays,” Bloomberg Law (February 24, 2021) (paywall)
Eleanor Laise, “Pfizer Suit Could Be an ‘Earthquake’ for Drug Pricing,” Barron’s (October 9, 2020) (paywall)
“Risk Adjustment Compliance Risks,” RISE National (March 2022)
“Using AI to Detect Medicare Fraud, Waste, and Abuse,” HIMSS Nevada Chapter (November 17, 2021) [paywall]
“Keys to Avoiding Legal Action in Medicare Fraud & Costly RADV Audit Mistakes – a Look into Recent Examples,” RISE West (September 2, 2021)
Super Lawyers, Rising Stars (2020-2024)
Georgetown University Law Center (2014)
University of Illinois (2010)